Study of rare cholesterol and fat disorders
Part of Heart & circulation, Hormones & metabolism clinical trials.
This study looks at people with rare or unusual cholesterol, fat, or heart-related conditions. It helps researchers learn more about these disorders and improve testing. You do not need to have a known diagnosis to join initially.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 10 years or older.
- You have a confirmed or suspected rare cholesterol, fat, or blood vessel condition.
- You are willing to undergo tests and procedures as part of the study.
- You can understand and sign a consent form (or have a parent or guardian do it for you).
- You are not a healthy volunteer without any lipid-related issues.
- If you are a healthy volunteer, you must have no known history of lipid disorders and not be pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how cholesterol and triglyceride levels change in people with dyslipidemia (unhealthy cholesterol/fat levels). Researchers want to understand what different causes mean for long-term health.
This study looks at people with unusual or rare heart problems, or people with a family history of these issues. Doctors and researchers may collect and study your blood or tissue (and possibly store samples) to learn what causes the condition and how it may affect the heart.
This trial tests if a computer-based tool helps doctors follow guidelines for managing dyslipidemia (high cholesterol or fats in the blood). You may join if you have enough medical data available and agree to participate.
This trial tests a new drug called HS-10582 in healthy people and those with slightly high LDL cholesterol (a type of cholesterol). The goal is to see if it is safe and how well your body handles it.
This study looks at body chemistry (cholesterol-related lab findings) and physical features in people with Smith-Lemli-Opitz syndrome and related rare genetic cholesterol disorders. It may help researchers better understand these conditions and how they affect the body.
This study observes people with lipodystrophy to better understand how the condition develops and affects the body over time. It may help researchers learn who is most affected and guide future treatments.
Hear when a new Dyslipidemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.